Theravance Biopharma Inc Annual Shareholders Meeting Transcript
Good afternoon, and welcome to the Theravance Biopharma 2021 Annual General Meeting of Shareholders. It's now 3:31 Irish Standard Time, and the meeting will please come to order. My name is Rick Winningham, and as Chairman of the Board and Chief Executive Officer of Theravance Biopharma, I will be presiding over this meeting.
I'd like to introduce the directors who are present today by telephone: Bob Gunderson, Burton Malkiel, Dean Mitchell, Susan Molineaux, Donal O'Connor, Deepa Pakianathan, Laurie Smaldone Alsup, George Whitesides, Bill Young and Eran Broshy. Also present today -- and George, yes, George Whitesides. Also present today is Ann Brady, President, Theravance Biopharma Ireland Limited; and also present today by telephone are Richard Ramko from Ernst & Young LLP, the company's independent public accounting firm; Judy To from Ernst & Young LLP, the company's independent public accounting firm; Andrew Hindman, Senior Vice President and Chief Financial Officer; Brad Shafer, Executive Vice President and General
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |